UK markets open in 3 hours 31 minutes
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,375.99 +168.86 (+0.93%) CRUDE OIL
79.15 +0.20 (+0.25%) GOLD FUTURES
2,309.90 +0.30 (+0.01%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,671.45 +1,832.45 (+4.00%)
TRACON Pharmaceuticals, Inc. (TCON)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 4.03M |
| Enterprise value | -4.30M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.24 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | -0.36 |
| Enterprise value/EBITDA | -1.15 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.04 |
| 52-week change 3 | -88.13% |
| S&P500 52-week change 3 | 21.33% |
| 52-week high 3 | 14.8000 |
| 52-week low 3 | 1.5900 |
| 50-day moving average 3 | 4.7581 |
| 200-day moving average 3 | 4.3111 |
Share statistics
| Avg vol (3-month) 3 | 250.18k |
| Avg vol (10-day) 3 | 182.84k |
| Shares outstanding 5 | 2.28M |
| Implied shares outstanding 6 | 2.28M |
| Float 8 | 2.08M |
| % held by insiders 1 | 2.59% |
| % held by institutions 1 | 11.71% |
| Shares short (15 Apr 2024) 4 | 24.41k |
| Short ratio (15 Apr 2024) 4 | 0.09 |
| Short % of float (15 Apr 2024) 4 | 1.08% |
| Short % of shares outstanding (15 Apr 2024) 4 | 1.07% |
| Shares short (prior month 15 Mar 2024) 4 | 94.86k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 08 Nov 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:20 |
| Last split date 3 | 10 Apr 2024 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -29.79% |
| Operating margin (ttm) | 13.37% |
Management effectiveness
| Return on assets (ttm) | -29.16% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 12.04M |
| Revenue per share (ttm) | 7.36 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -6.88M |
| Net income avi to common (ttm) | -3.59M |
| Diluted EPS (ttm) | -2.2000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 8.56M |
| Total cash per share (mrq) | 3.76 |
| Total debt (mrq) | 968k |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.89 |
| Book value per share (mrq) | -0.37 |
Cash flow statement
| Operating cash flow (ttm) | 3.68M |
| Levered free cash flow (ttm) | -1.72M |
© 2024 Yahoo. All rights reserved.